📰 Sarepta Elevidys News
Sarepta Elevidys News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sarepta Elevidys. Real-time updates on events, politics, business and more.
April 1, 2024
With several recent approvals in the space and more on the horizon, BioSpace looks at some of the key decisions and their larger significance both for patients and science.
March 13, 2024
The threat is still emerging, but it could be significant.
February 20, 2024
Novo Nordisk recently acquired three manufacturing facilities from contract development and manufacturing organization Catalent, in a bold move that has sparked a great deal of debate and some backlash.
October 31, 2023
Sarepta Therapeutics’ Elevidys failed to meet its primary endpoint in a Phase 3 trial, shortly after the FDA granted it accelerated approval for Duchenne muscular dystrophy.
June 23, 2023
June 23 (Reuters) - Sarepta Therapeutics shares slumped 11% on Friday as some analysts voiced concerns that upcoming confirmatory trial data for its gene therapy to treat Duchenne muscular dystrophy (DMD) may not be enough to secure approva...
June 23, 2023
(Reuters) - Sarepta Therapeutics shares slumped 11% on Friday as some analysts voiced concerns that upcoming confirmatory trial data for its gene ther...